IL6 and hypertensive disorder: TNF-α and IL-1β levels, counter regulated by IL-6 and soluble TNF-α receptor/soluble TNF-α receptor 2 (sTNFR1/sTNFR2) by TNF-α, correlate with impaired endothelium-dependent dilatation and induction of insulin resistance followed by high blood pressure, respectively [16].